My Application Form Status

Check the status of your application form with Angel Broking.
  • Companies
  • Everything else
Search
Sagar Cements gains as board sets decent premium for preferential share allotment
Nov 28,2016

The announcement was made during trading hours today, 28 November 2016.

Meanwhile, the BSE Sensex was up 76 points, or 0.29%, to 26,392.34.

On BSE, so far 64,000 shares were traded in the counter, compared with average daily volume of 3,648 shares in the past one quarter. The stock hit a high of Rs 729.50 and a low of Rs 605 so far during the day. The stock hit a record high of Rs 835 on 14 October 2016. The stock hit a 52-week low of Rs 350 on 18 February 2016. The stock had underperformed the market over the past 30 days till 25 November 2016, falling 15.67% compared with the 5.73% decline in the Sensex. The scrip had, however, outperformed the market in past one quarter, falling 4.66% as against Sensexs 5.28% decline.

The small-cap company has equity capital of Rs 17.39 crore. Face value per share is Rs 10.

Sagar Cements said that the board at its meeting held on 28 November 2016, fixed an issue price of Rs 800 per equity share for the proposed issue of 6.11 lakh equity shares of the company on a preferential basis, subject to receipt of further necessary approvals as may be required.

The issue price is 10.07% premium to the ruling market price. It is 29.05% premium to the previous closing price of Rs 619.90 on Friday, 25 November 2016.

The company announced on 23 November 2016, that its shareholders at the extraordinary general meeting (EGM) held on that day, voted on a resolution of issuing up to 6.11 equity shares on a preferential basis and the outcome of the said voting is awaited.

Net profit of Sagar Cements declined 71.53% to Rs 2.50 crore on 29% decline in net sales to Rs 119.20 crore in Q2 September 2016 over Q2 September 2015.

Sagar Cements is engaged in manufacturing of cement.

Powered by Capital Market - Live News

Suzlon Energy gains after winning order
Nov 28,2016

The announcement was made during trading hours today, 28 November 2016.

Meanwhile, the BSE Sensex was up 64.45 points, or 0.24%, to 26,380.79.

On BSE, so far 11.36 lakh shares were traded in the counter, compared with average daily volume of 45.11 lakh shares in the past one quarter. The stock hit a high of Rs 14.96 and a low of Rs 14.48 so far during the day. The stock hit a 52-week high of Rs 23.25 on 5 January 2016. The stock hit a 52-week low of Rs 12.47 on 9 November 2016. The stock had outperformed the market over the past 30 days till 25 November 2016, falling 0.21% compared with the 5.73% decline in the Sensex. The scrip had, however, underperformed the market in past one quarter, sliding 9.72% as against Sensexs 5.28% decline.

The mid-cap company has equity capital of Rs 1004.88 crore. Face value per share is Rs 2.

Suzlon Energy announced its order win of 50.40 megawatt (MW) wind power project from a leading business house. The project consists of 24 units of S95 90m tubular tower with rated capacity of 2.1 MW.

Located in the district of Anantapur, Andhra Pradesh, the project is scheduled for completion in March 2017. This order win takes the total current year order portfolio with the business house to 84 MW out of which 33.60 MW was announced earlier as a part of order wins from SMEs.

Suzion will provide comprehensive operation and maintenance for a period of 20 years and includes dedicated Life cycle asset management services to the project. The project has the potential to provide power to over 27,000 households and reduce 0.10 million tonnes of CO2 emissions per annum.

On a consolidated basis, Suzlon Energy reported net profit of Rs 237.62 crore in Q2 September 2016 as against net loss of Rs 201.66 crore in Q2 September 2015. Net sales rose 57.30% to Rs 2746.18 crore in Q2 September 2016 over Q2 September 2015.

Suzion Energy is one of the leading renewable energy solutions providers in the world with an international presence across 19 countries in Asia, Australia, Europe, Africa and North and South America.

Powered by Capital Market - Live News

Persistent Systems trims intraday gains tracking fund selling
Nov 28,2016

Meanwhile, the S&P BSE Sensex was up 58.52 points or 0.22% at 26,374.86.

On BSE, so far 12,000 shares were traded in the counter as against average daily volume of 13,487 shares in the past one quarter. The stock was volatile. The stock rose as much as 1.45% at the days high of Rs 612 so far during the day. The stock lost as much as 0.2% at the days low of Rs 602 so far during the day. The stock had hit a 52-week low of Rs 501.10 on 28 September 2016. The stock had hit a 52-week high of Rs 796.75 on 21 March 2016. The stock had underperformed the market over the past one month till 25 November 2016, declining 8.48% compared with the Sensexs 6.32% fall. The scrip had also underperformed the market in past one quarter, sliding 6.12% as against the Sensexs 5.46% fall.

The mid-cap company has equity capital of Rs 80 crore. Face value per share is Rs 10.

On a consolidated basis, Persistent Systems net profit rose 0.27% to Rs 73.49 crore on 0.31% growth in net sales to Rs 704.02 crore in Q2 September 2016 over Q1 June 2016.

Persistent Systems builds software that drives the business of our customers; serving software product companies and enterprises with software at the core of their digital transformation.

Powered by Capital Market - Live News

Uflex jumps after good Q2 results
Nov 28,2016

The result was announced after market hours on Friday, 25 November 2016.

Meanwhile, the BSE Sensex was up 38.37 points, or 0.15%, to 26,354.71.

On BSE, so far 1.01 lakh shares were traded in the counter, compared with average daily volume of 68,480 shares in the past one quarter. The stock hit a high of Rs 278.80 and a low of Rs 271 so far during the day. The stock hit a 52-week high of Rs 334 on 27 October 2016. The stock hit a 52-week low of Rs 132.20 on 29 February 2016. The stock had underperformed the market over the past 30 days till 25 November 2016, falling 16.36% compared with the 5.73% decline in the Sensex. The scrip had, however, outperformed the market in past one quarter, rising 10.72% as against Sensexs 5.28% decline.

The small-cap company has equity capital of Rs 72.21 crore. Face value per share is Rs 10.

Uflexs consolidated earnings before interest, tax, depreciation and amortization (EBITDA) rose by 6% and stood at Rs 233.10 crore in Q2 September 2016 over Q2 September 2015.

Commenting on Q2 results, R.K. Jain, Group President (Corp. F & A) Uflex said that the companys raw material prices are linked to crude oil prices. The downward pressure of raw material prices over the past few quarters has been retaining the selling prices of the goods on the downside. Therefore, while the volumes have grown, the total revenue has not shown growth during the period. The volume of packaging films has gone up by 14% in Q2 September 2016 over Q2 September 2015. Volume of packaging products has gone up by 5% in Q2 September 2016 over Q2 September 2015. Thus the company has registered a 12% growth in overall volume in Q2 September 2016 over Q2 September 2015.

In a separate announcement after market hours on Friday, 25 November 2016, Uflex said that its board has approved the issuance of redeemable non-convertible secured debentures (NCDs)/bonds upto an amount of Rs 650 crore on private placement basis.

Uflex is Indias largest end-to-end flexible packaging company and an emerging global player.

Powered by Capital Market - Live News

Cipla moves higher on reports of plans to sell animal health unit
Nov 28,2016

Meanwhile, the S&P BSE Sensex was up 4.07 points or 0.02% at 26,320.41.

On BSE, so far 56,000 shares were traded in the counter as against average daily volume of 1.66 lakh shares in the past one quarter. The stock hit a high of Rs 577 and a low of Rs 567.80 so far during the day. The stock had hit a 52-week high of Rs 660 on 29 December 2015. The stock had hit a 52-week low of Rs 458.25 on 25 May 2016. The stock had outperformed the market over the past one month till 25 November 2016, declining 3.75% compared with the Sensexs 6.32% fall. The scrip had also outperformed the market in past one quarter, advancing 0.05% as against the Sensexs 5.46% fall.

The large-cap company has equity capital of Rs 160.85 crore. Face value per share is Rs 2.

Media reports suggested that Cipla has hired global investment bank Rothschild to find potential buyers. Several Indian buyers have submitted bids for Cipla Vet, reports added. Cipla Vet is a leading veterinary pharmaceutical exporter with a presence in over 100 countries. Ciplas move to sell its veterinary business comes in the backdrop of its overall plan to rationalize its markets and portfolio and exit non-core, low-profit businesses, reports suggested.

On a consolidated basis, Ciplas net profit dropped 34.7% to Rs 354.34 crore on 8.7% rise in net sales to Rs 3671.88 crore in Q2 September 2016 over Q2 September 2015.

Cipla is a global pharmaceutical company.

Powered by Capital Market - Live News

Strides Shasun gains after acquisition
Nov 28,2016

The announcement was made after market hours on Friday, 25 November 2016.

Meanwhile, the BSE Sensex was down 67.76 points, or 0.26%, to 26,248.58.

On BSE, so far 9,778 shares were traded in the counter, compared with average daily volume of 67,539 shares in the past one quarter. The stock hit a high of Rs 1,100 and a low of Rs 1,077 so far during the day. The stock hit a 52-week high of Rs 1,400 on 10 December 2015. The stock hit a 52-week low of Rs 848 on 29 February 2016. The stock had outperformed the market over the past 30 days till 25 November 2016, rising 14.98% compared with the 5.73% decline in the Sensex. The scrip had also outperformed the market in past one quarter, rising 13.44% as against Sensexs 5.28% decline.

The mid-cap company has equity capital of Rs 89.37 crore. Face value per share is Rs 10.

Strides Shasun announced that its wholly-owned subsidiary Strides Arcolab International, UK has entered into an agreement with Moberg Pharma, Sweden to acquire the PediaCare brand for a total consideration of $5 million plus inventory value at closing.

PediaCare is an established paediatric cough, cold and allergy brand with annual sales of approximately $6 million. PediaCare will form an important part of Strides expanding consumer health care portfolio and brings with it expertise in the paediatric segment as well as a strong brand name with global potential.

Strides Shasuns consolidated net profit rose 106.90% to Rs 74.09 crore on 36.26% rise in net sales to Rs 922.17 crore in Q2 September 2016 over Q2 September 2015.

Strides Shasun is a vertically integrated global pharmaceutical company headquartered inBangalore.

Powered by Capital Market - Live News

Bharti Airtel heads north after completing a stake acquisition in Airtel Nigeria
Nov 28,2016

The announcement was made on Saturday, 26 November 2016.

Meanwhile, the S&P BSE Sensex was down 28.16 points or 0.11% at 26,288.18.

On BSE, so far 25,000 shares were traded in the counter as against average daily volume of 3.15 lakh shares in the past one quarter. The stock hit a high of Rs 307.80 and a low of Rs 301 so far during the day. The stock had hit a 52-week high of Rs 384.90 on 28 April 2016. The stock had hit a 52-week low of Rs 282.30 on 29 January 2016. The stock had outperformed the market over the past one month till 25 November 2016, declining 3.28% compared with the Sensexs 6.32% fall. The scrip had, however, underperformed the market in past one quarter, sliding 13.09% as against the Sensexs 5.46% fall.

The large-cap company has equity capital of Rs 1998.70 crore. Face value per share is Rs 5.

Bharti Airtel announced that Bharti Airtel International (Netherlands) BV through its wholly owned subsidiary (Airtel), has completed the acquisition of Econet Wireless entire 4.2% shareholding in Airtel Nigeria. As a result, Airtels overall holding in Airtel Nigeria has increased to 83.25%.

On consolidated basis, Bharti Airtels net profit declined 4.9% to Rs 1460.70 crore on 3.4% growth in net sales to Rs 24651.50 crore in Q2 September 2016 over Q2 September 2015.

Bharti Airtel is a leading global telecommunications company with operations in 18 countries across Asia and Africa.

Powered by Capital Market - Live News

Hathway Cable & Datacom tumbles after poor Q2 performance
Nov 28,2016

The result was announced after market hours on Friday, 25 November 2016.

Meanwhile, the BSE Sensex was down 64.25 points, or 0.24%, to 26,252.09.

On BSE, so far 26,000 shares were traded in the counter, compared with average daily volume of 69,878 shares in the past one quarter. The stock hit a high of Rs 33.50 and a low of Rs 32.25 so far during the day. The stock hit a 52-week high of Rs 48 on 4 December 2015. The stock hit a 52-week low of Rs 24 on 30 September 2016. The stock had outperformed the market over the past 30 days till 25 November 2016, rising 11.61% compared with the 5.73% decline in the Sensex. The scrip had also outperformed the market in past one quarter, rising 16.11% as against Sensexs 5.28% decline.

The small-cap company has equity capital of Rs 166.10 crore. Face value per share is Rs 2.

Hathway Cable & Datacoms net sales rose 18.59% to Rs 318.84 crore in Q2 September 2016 over Q2 September 2015.

EBITDA (earnings before interest, taxes, depreciation and amortization) rose 12% to Rs 54.90 crore in Q2 September 2016 over Q2 September 2015. EBITDA margin stood at 17% in Q2 September 2016 compared with 18% in Q2 September 2015.

The companys revenue from the broadband business rose 67% to Rs 120.30 crore in Q2 September 2016 over in Q2 September 2015.

The companys net debt stood at Rs 1636 crore in Q2 September 2016 compared with net debt of Rs 1564.80 crore Q1 June 2016.

Hathway Cable & Datacom offers cable television services across 140 cities and towns and high-speed cable broadband services across 21 cities.

Powered by Capital Market - Live News

Aurobindo Pharma inches up after pact with Teva in France
Nov 28,2016

The announcement was made after market hours on Friday, 25 November 2016.

Meanwhile, the S&P BSE Sensex was down 60.06 points or 0.23% at 26,256.28.

On BSE, so far 9,326 shares were traded in the counter as against average daily volume of 2.12 lakh shares in the past one quarter. The stock hit a high of Rs 748.45 and a hit a low of Rs 739 so far during the day. The stock had hit a record high of Rs 895 on 6 October 2016. The stock had hit a 52-week low of Rs 582 on 25 February 2016. The stock had underperformed the market over the past one month till 25 November 2016, declining 10.23% compared with the Sensexs 6.32% fall. The scrip had also underperformed the market in past one quarter, sliding 6.25% as against the Sensexs 5.46% fall.

The large-cap company has equity capital of Rs 58.52 crore. Face value per share is Rs 1.

Aurobindo Pharmas French subsidiary Arrow Generiques SAS (Arrow Generiques) will acquire the right, title and interest in products calcium and calcium vitamin D3, including the use of the OROCAL trademark. The transaction is subject to the approval of the European Commission. Following receipt of clearances from European authorities, Arrow Generiques will integrate these products with its existing commercial operations in France, and focus on maximizing their potential. Arrow Generiques and Teva intend to ensure continuity of the supply of the products to the market. This acquisition will enable Arrow Generiques to continue to increase its branded products portfolio and leverage its position as a key player in the drug market. Arrow Generiques is a pharmaceutical company with focus on selling generics on the retail and hospital markets in France since 2002.

On consolidated basis, Aurobindo Pharmas net profit rose 33.5% to Rs 605.64 crore on 12.1% growth in net sales to Rs 3713.58 crore in Q2 September 2016 over Q2 September 2015.

Aurobindo Pharma manufactures generic pharmaceuticals and active pharmaceutical ingredients. The companys manufacturing facilities are approved by several leading regulatory agencies like US FDA, UK MHRA, Japan PMDA, WHO, Health Canada, MCC South Africa, ANVISA Brazil. The companys robust product portfolio is spread over 7 major therapeutic/product areas encompassing Antibiotics, Anti-Retrovirals, CVS, CNS, Gastroenterological, Anti-Allergies and Anti-Diabetes, supported by an outstanding R&D set-up. The company is marketing these products globally in over 150 countries

Powered by Capital Market - Live News

Maruti Suzuki gains after announcing launch of Wagon R Felicity limited edition
Nov 25,2016

The announcement was made during market hours today, 25 November 2016.

Meanwhile, the S&P BSE Sensex was up 471.29 points or 1.82% at 26,331.46

On BSE, so far 32,000 shares were traded in the counter as against average daily volume of 65,374 shares in the past one quarter. The stock hit a high of Rs 4,904.50 and a low of Rs 4,795.65 so far during the day. The stock had hit a 52-week high of Rs 5,972 on 1 November 2016. The stock had hit a 52-week low of Rs 3,202.10 on 29 February 2016. The stock had underperformed the market over the past 30 days till 24 November 2016, falling 17.6% compared with the 7.10% decline in the Sensex. The scrip, however, outperformed the market in past one quarter, falling 1.67% as against Sensexs 6.92% decline.

The large-cap company has equity capital of Rs 151.04 crore. Face value per share is Rs 5.

Maruti Suzuki India said that Wagon R Felicity offers a wide array of features including reverse parking sensors with display and voice guidance, double-din bluetooth music system with speakers, available in Lxi variant. The celebration edition is equipped with PU seats and steering cover, body graphics, rear spoiler to make it even more attractive, Maruti Suzuki India said.

Introducing the Wagon R Felicity limited edition R. S. Kalsi, Executive Director Marketing & Sales, Maruti Suzuki India said that Wagon R Felicity will appeal to Wagon R loyalists as well as compact car customers who are looking for a product that is unique and distinct. Besides the manual transmission, Wagon R is available with the AMT option. It is offered in petrol as well as CNG, the company said. Wagon R Felicity limited edition will be available in two variants - Lxi and Vxi with all existing fuel and transmission options. The limited edition Wagon R Felicity is available in the price range of Rs 4.40 lakh for Lxi to Rs 5.37 lakh for Vxi-AMT (O) variants.

Maruti Suzuki Indias net profit rose 60.2% to Rs 2398 crore on 29.5% growth in net sales to Rs 17594.60 crore in Q2 September 2016 over Q2 September 2015.

Maruti Suzuki India is Indias biggest car maker in terms of market share. Japanese parent Suzuki Motor Corporation currently holds 56.21% stake in Maruti (as per the shareholding pattern as on 30 September 2016).

Powered by Capital Market - Live News

Steel Strips Wheels gains after winning order
Nov 25,2016

The announcement was made during trading hours today, 25 November 2016.

Meanwhile, the BSE Sensex was up 427.07 points, or 1.65%, to 26,287.24.

On BSE, so far 7,725 shares were traded in the counter, compared with average daily volume of 10,177 shares in the past one quarter. The stock hit a high of Rs 546.25 and a low of Rs 511 so far during the day. The stock hit a record high of Rs 775 on 14 October 2016. The stock hit a 52-week low of Rs 284 on 17 February 2016. The stock had underperformed the market over the past 30 days till 24 November 2016, falling 24.16% compared with the 7.10% decline in the Sensex. The scrip had also underperformed the market in past one quarter, falling 10.41% as against Sensexs 6.92% decline.

The small-cap company has equity capital of Rs 15.53 crore. Face value per share is Rs 10.

Steel Strips Wheels (SSWL) said the total order is for supplying approximately 20,000 wheels. Orders will be executed from SSWLs Chennai plant with shipments starting from December 2016. This is a repeat order from the export customer.

The company has also bagged an order to supply wheels to BMW India. The total order size is 18,000 wheels and the order will start for mass supplies from March 2017 from the companys Chennai facility.

This order marks strong competence of SSWL in both export and high end segments of the market. SSWL is expecting to receive additional orders for the Caravan wheels from other European Union (EU) customers in coming weeks.

Net profit of SSWL rose 19.9% to Rs 18.02 crore on 2.8% decline in net sales to Rs 290.95 crore in Q2 September 2016 over Q2 September 2015.

SSWL designs and manufactures automotive steel wheels and is among the leading supplier to Indian and global automobile manufacturers.

Powered by Capital Market - Live News

Bata India gains after Q2 results
Nov 25,2016

The result was announced during trading hours today, 25 November 2016.

Meanwhile, the BSE Sensex was up 381.93 points, or 1.48%, to 26,242.10.

On BSE, so far 1.30 lakh shares were traded in the counter, compared with average daily volume of 44,914 shares in the past one quarter. The stock hit a high of Rs 418.35 and a low of Rs 400 so far during the day. The stock hit a 52-week high of Rs 613.55 on 1 August 2016. The stock hit a 52-week low of Rs 400 on 25 November 2016. The stock had underperformed the market over the past 30 days till 24 November 2016, falling 16% compared with the 7.10% decline in the Sensex. The scrip had also underperformed the market in past one quarter, falling 24.59% as against Sensexs 6.92% decline.

The mid-cap company has equity capital of Rs 64.26 crore. Face value per share is Rs 5.

Bata Indias net profit fell 36.36% to Rs 34.59 crore on 2.29% increase in total income to Rs 597.81 crore in Q2 September 2016 over Q2 September 2015.

The quarter saw the company strengthening its mens contemporary range with the launch of Bata European collection, an entry in the womens festive segment and expansion of omni-channel presence across stores, the company said in a statement.

Bata India is the largest footwear retailer in India, offering footwear, accessories and bags across brands like Bata, Hush Puppies, Naturalizer, Power, Marie Claire, Weinbrenner, North Star, Scholl, Bata Comfit and Bubblegummers to name a few. It retails in over 1,265 Bata stores, on bata.in and in thousands of multi-brand footwear dealer stores pan-India.

Powered by Capital Market - Live News

Amtek Auto leads gainers in A group
Nov 25,2016

Amtek Auto jumped 11.35% to Rs 75.90 at 14:45 IST. The stock topped the gainers in the BSEs A group. On BSE, so far 12.14 lakh shares were traded in the counter as against average daily volume of 4.10 lakh shares in the past two weeks.

PI Industries galloped 9.63% to Rs 890. The stock was second biggest gainer in A group. On BSE, so far 33,000 shares were traded in the counter as against average daily volume of 21,000 shares in the past two weeks.

Tata Elxsi spurted 8.51% to Rs 1,255.30. The stock was third biggest gainer in A group. On BSE, so far 2.87 lakh shares were traded in the counter as against average daily volume of 82,000 shares in the past two weeks.

Unitech gained 7.91% to Rs 4.91. The stock was fourth biggest gainer in A group. On BSE, so far 27.22 lakh shares were traded in the counter as against average daily volume of 28.68 lakh shares in the past two weeks.

Hexaware Technologies rose 7.27% to Rs 204.30. The stock was fifth biggest gainer in A group. On BSE, so far 2.16 lakh shares were traded in the counter as against average daily volume of 74,000 shares in the past two weeks.

Powered by Capital Market - Live News

Volumes jump at Indoco Remedies counter
Nov 25,2016

Indoco Remedies clocked volume of 2.02 lakh shares by 14:21 IST on BSE, a 54.22-times surge over two-week average daily volume of 4,000 shares. The stock fell 1.07% to Rs 272.25.

IIFL Holdings notched up volume of 10.19 lakh shares, a 49.97-fold surge over two-week average daily volume of 20,000 shares. The stock rose 5.77% to Rs 272.

AIA Engineering saw volume of 2.02 lakh shares, a 37.54-fold surge over two-week average daily volume of 5,000 shares. The stock rose 4.25% to Rs 1,264.

GlaxoSmithkline Consumer Healthcare clocked volume of 24,000 shares, a 30.84-fold surge over two-week average daily volume of 1,000 shares. The stock fell 1.38% to Rs 5,014.10.

Vinati Organics saw volume of 1.26 lakh shares, a 30.39-fold rise over two-week average daily volume of 4,000 shares. The stock rose 2.67% to Rs 558.90.

Powered by Capital Market - Live News

J Kumar Infraprojects spurts after winning DMRC contract
Nov 25,2016

The announcement was made during trading hours today, 25 November 2016.

Meanwhile, the BSE Sensex was up 377.65 points, or 1.46%, to 26,237.82.

On BSE, so far 1.95 lakh shares were traded in the counter, compared with average daily volume of 1.54 lakh shares in the past one quarter. The stock hit a high of Rs 208 and a low of Rs 176.50 so far during the day. The stock hit a 52-week high of Rs 399 on 6 January 2016. The stock hit a 52-week low of Rs 105.80 on 17 August 2016. The stock had underperformed the market over the past 30 days till 24 November 2016, falling 18.63% compared with the 7.10% decline in the Sensex. The scrip had, however, outperformed the market in past one quarter, rising 8.17% as against Sensexs 6.92% decline.

The small-cap infrastructure company has equity capital of Rs 37.83 crore. Face value per share is Rs 5.

J Kumar Infraprojects, on behalf of the J. Kumar Infra - CRTG JV, signed an agreement with the Delhi Metro Rail Corporation (DMRC) worth of Rs 1344.93 crore on Thursday, 24 November 2016, for Phase-2 of the Mumbai metro project and other projects worth Rs 449.19 crore.

Net profit of J Kumar Infraprojects rose 15.63% to Rs 29.52 crore on 10.13% rise in net sales to Rs 390.54 crore in Q1 June 2016 over Q1 June 2015.

J Kumar Infraprojects is renowned for undertaking design and construction projects on a turnkey basis.

Powered by Capital Market - Live News